Free Cash Flow

Firestorm Labs' new award will deploy containerized drone factories to the Indo-Pacific, a major shift in military logistics to counter supply chain threats.

Vancouver's ME Therapeutics will unveil its in-vivo immune reprogramming technology, a potential cancer treatment game-changer, to global investors.

Phoenix-based DarkPulse gets exclusive rights to the Navy's cutting-edge laser targeting tech, but can the firm overcome financial hurdles to succeed?

The payments firm beat revenue estimates and reaffirmed guidance, sparking a 15% stock rally and signaling resilience amid global economic headwinds.

The optical giant enters the AI data center market and details its AR ambitions while shedding assets to deleverage and target sustainable cash flow.

Amid rising global conflicts, BAE Systems reaffirms strong growth, fueled by record defense budgets and major contracts for air, space, and sea power.

Despite challenging markets, Acadian Timber posts steady Q1 results, fueled by a major operational turnaround in Maine and a strategic eye on carbon credits.

With record revenue and surging EPS, Element Fleet's tech-forward strategy is paying off, solidifying its market lead even as some competitors contract.

Pattern's AI-powered platform shatters Q1 records with 43% revenue growth and 127% NRR, raising its 2026 outlook amid explosive diversification.

Canada's top gas producer leverages international LNG markets and deep cost cuts to post record production and a robust $0.9 billion free cash flow forecast.

HighPeak Energy posted strong Q1 operational results, but a $157M derivative loss highlights the challenges of navigating a volatile, geopolitically charged market.

Diathrive Health and AliveCor's KardiaComplete partner to offer an integrated solution for diabetes and heart disease, combating fragmented care and rising costs.

Riding a wave of strong earnings and bold broadband plays, T-Mobile executives are set to outline the Un-carrier's future. Here's what's at stake.

With a promising cancer pipeline, Crescent Biopharma heads to key May conferences to prove its strategy against fierce competition in the bispecific and ADC markets.

Twin Disc reverses a prior-year loss with a $3.3M profit, driven by a 19% sales jump and record backlog, signaling a strong strategic turnaround.

Littelfuse stock rises after crushing Q1 earnings estimates, fueled by the Basler acquisition and robust demand across its electronics and auto segments.

Ohio Peterbilt is opening a state-of-the-art dealership in Etna, a major investment in the Midwest logistics corridor celebrated with TV's Diesel Brothers.

A new report reveals 59% of firms made a "bad AI hire" last year. Discover the costly paradox and why traditional hiring methods are failing.

As registration opens, wire & Tube China 2026 is set to be a crucial barometer for global manufacturing, showcasing innovation and China's pivotal market role.

Minerva Neurosciences launches a pivotal Phase 3 trial for roluperidone, a potential first-in-class drug for the untreated negative symptoms of schizophrenia.